£23.0M
The financing round was led by aMoon and will support clinical trials and research pipelines.
"Since the inception of MiNA Therapeutics, we have been focused on advancing the Company by validating our innovative therapeutic approach in patients and establishing strategic collaborations with leading academic institutions and industry partners,"
